Datwyler AGM approves all proposals of the Board

The Annual General Meeting approved a stable dividend of CHF 3.20 per bearer share and CHF 0.64 per registered share. A solid free cash flow in the 2024 reporting year made it possible to further strengthen the balance sheet and keep the dividend payment stable. The dividend will be paid out free of charges from 24 March 2025 by means of coupon no. 19. The first trading date without dividend entitlement (ex-date) is 20 March 2025.

All Directors were re-elected for a further one year term of office. The special meeting of the bearer share holders elected the existing Board members Martin Hirzel and Dirk Lambrecht as well as new member Britt Hendriksen as their representatives. Britt Hendriksen has extensive experience in the global healthcare industry, most recently as Group CFO of Unilabs, a leading provider of diagnostic services. Previously, she held various global management positions at Novartis for more than 20 years, including CFO Global Drug Development and CFO of the Asia Pacific region. The Board of Directors now consists of nine members and will continue to be chaired by Paul Hälg. Hanspeter Fässler (Chairman), Claude R. Cornaz and Jens Breu were re-elected as members of the Nomination and Compensation Committee. The Audit Committee consists of Jürg Fedier (Chairman), Gabi Huber and Martin Hirzel. KPMG was confirmed as auditor for a further year.